image
Castle Biosciences, Inc. CSTL
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 28.1
-8.86 %
$ 787 M
Market Cap
133.81
P/E
INCOME STATEMENT
220 M REVENUE
60.38%
Growth Rates
1Year 60.38%
3Years 51.95%
5Years 57.35%
7Years 0.00%
10Years 0.00%
-68 M OPERATING INCOME
25.42%
Growth Rates
1Year 25.42%
3Years -118.21%
5Years -77.71%
7Years 0.00%
10Years 0.00%
-57.5 M NET INCOME
14.41%
Growth Rates
1Year 14.41%
3Years -77.45%
5Years -55.27%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Castle Biosciences, Inc.
image
Revenue 220 M
Cost Of Revenue 45 M
Gross Profit 175 M
Operating Expenses 243 M
Operating Income -68 M
Other Expenses -10.5 M
Net Income -57.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 219.8 137.0 94.1 62.6 51.9 22.8 13.8
GROSS PROFIT
Cost Of Revenue 45.0 32.0 15.8 9.7 7.3 5.3 4.9
Gross Profit 174.8 105.0 78.3 53.0 44.6 17.5 8.8
OPERATING INCOME
Operating Expenses 242.8 196.2 118.3 59.5 37.2 21.3 19.7
Selling, General and Administrative Expenses 180.2 143.0 86.7 48.1 29.8 16.5 15.3
Research and Development Expenses 53.6 44.9 29.6 13.3 7.4 4.9 4.5
Operating Income (68.0) (91.1) (40.1) (6.5) 4.7 (3.8) (10.9)
PRE-TAX INCOME
Interest Income Expense 11 K 17 K 1 K 2.6 4.6 2.3 1.6
Total Other Income 10.6 4.0 67 K (3.7) (2.0) (2.5) (1.5)
Pre-Tax Income (57.4) (68.9) (40.0) (10.2) 5.3 (6.4) (12.4)
NET INCOME
Tax Provision 0.1 (1.8) (8.7) 84 K 72 K 8.61 K 9.73 K
Net Income (57.5) (67.1) (31.3) (10.3) 5.3 (6.4) (12.4)
EPS 2.14 2.58 1.24 0.54 0.35 0.6 1.26